https://clinicaltrialhub.org/2026-04-14T21:33:00.809Z1.0https://clinicaltrialhub.org/about/2026-04-14T21:33:00.809Z0.5https://clinicaltrialhub.org/city/houston-texas/2026-04-14T21:33:00.809Z0.5https://clinicaltrialhub.org/city/los-angeles-california/2026-04-14T21:33:00.809Z0.5https://clinicaltrialhub.org/city/new-york-new-york/2026-04-14T21:33:00.809Z0.5https://clinicaltrialhub.org/condition/alzheimers-disease/2026-04-14T21:33:00.809Z0.9https://clinicaltrialhub.org/condition/breast-cancer/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/breast-cancer/california/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/breast-cancer/new-york/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/depression/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/heart-failure/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/hiv/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/lung-cancer/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/rheumatoid-arthritis/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/type-2-diabetes/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/condition/type-2-diabetes/texas/2026-04-14T21:33:00.810Z0.9https://clinicaltrialhub.org/conditions/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/drug/example-drug/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/drug/novel-medication/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/faq/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/adaptive-design/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/adjuvant-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/adverse-event/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/assent/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/baseline/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/bioavailability/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/biomarker/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/breakthrough-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/chemotherapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/clinical-research-organization/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/cohort/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/combination-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/comorbidity/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/compassionate-use/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/complete-response/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/confidence-interval/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/contraindication/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/control-group/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/crossover/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/data-safety-monitoring-board/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/dose-escalation/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/dose-limiting-toxicity/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/double-blind/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/ecog-score/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/eligible/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/ema/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/emergency-use-authorization/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/endpoint/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/enrolled/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/exclusion-criteria/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/expanded-access/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/fast-track/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/fda/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/genetic-testing/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/good-clinical-practice/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/half-life/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/hazard-ratio/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/healthy-volunteer/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/immunotherapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/inclusion-criteria/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/ind/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/ineligible/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/informed-consent/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/institutional-review-board/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/intent-to-treat/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/interim-analysis/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/interventional-study/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/investigational-drug/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/irb/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/maintenance-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/maximum-tolerated-dose/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/monoclonal-antibody/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/multicenter/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/nda/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/neoadjuvant-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/observational-study/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/open-label/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/orphan-drug/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/overall-survival/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/p-value/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/palliative-care/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/parallel-group/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/partial-response/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/per-protocol/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/performance-status/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/pharmacodynamics/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/pharmacokinetics/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/placebo-controlled/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/placebo/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/power/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/primary-endpoint/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/principal-investigator/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/prior-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/progression-free-survival/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/progression/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/randomization/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/randomized/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/registry/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/regulatory-approval/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/remission/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/response-rate/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/sample-size/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/screening/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/secondary-endpoint/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/serious-adverse-event/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/single-blind/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/single-center/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/sponsor/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/stable-disease/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/standard-of-care/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/statistical-significance/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/stratification/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/surrogate-endpoint/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/targeted-therapy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/treatment-arm/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/glossary/washout-period/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/guides/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/caregiver-guide-to-clinical-trials/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/clinical-trial-myths/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/clinical-trials-for-children/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/clinical-trials-for-rare-diseases/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/how-to-join-a-clinical-trial/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/how-to-read-eligibility-criteria/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/questions-to-ask-your-doctor/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/understanding-informed-consent/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/what-are-trial-phases/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/guides/what-is-a-clinical-trial/2026-04-14T21:33:00.810Z0.7https://clinicaltrialhub.org/phase/phase2/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/phase/phase3/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/privacy/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/state/california/2026-04-14T21:33:00.810Z0.6https://clinicaltrialhub.org/state/new-york/2026-04-14T21:33:00.810Z0.6https://clinicaltrialhub.org/state/texas/2026-04-14T21:33:00.810Z0.6https://clinicaltrialhub.org/thanks/2026-04-14T21:33:00.810Z0.5https://clinicaltrialhub.org/trial/example-trial-for-breast-cancer-treatment-study-nct00000001/2026-04-14T21:33:00.810Z0.8https://clinicaltrialhub.org/trial/type-2-diabetes-new-medication-study-nct00000002/2026-04-14T21:33:00.810Z0.8